X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23259) 23259
Publication (1233) 1233
Book Chapter (61) 61
Book Review (33) 33
Magazine Article (15) 15
Conference Proceeding (14) 14
Dissertation (6) 6
Paper (3) 3
Book / eBook (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (12213) 12213
humans (9770) 9770
l-lactate dehydrogenase - metabolism (8796) 8796
male (8476) 8476
index medicus (6622) 6622
rats (5736) 5736
female (5628) 5628
l-lactate dehydrogenase - analysis (5353) 5353
l-lactate dehydrogenase - blood (5095) 5095
l-lactate dehydrogenase (3444) 3444
lactate dehydrogenase (3108) 3108
adult (2873) 2873
middle aged (2742) 2742
mice (2529) 2529
lactic acid (2517) 2517
isoenzymes (2295) 2295
cells, cultured (2216) 2216
biochemistry & molecular biology (2154) 2154
apoptosis (2097) 2097
oxidative stress (2078) 2078
aged (2010) 2010
time factors (1934) 1934
pharmacology & pharmacy (1818) 1818
toxicology (1696) 1696
analysis (1673) 1673
enzymes (1584) 1584
aspartate aminotransferases - blood (1464) 1464
cell survival - drug effects (1437) 1437
oncology (1426) 1426
proteins (1405) 1405
rats, wistar (1392) 1392
rats, sprague-dawley (1363) 1363
dose-response relationship, drug (1359) 1359
expression (1329) 1329
metabolism (1250) 1250
cell biology (1228) 1228
neurosciences (1208) 1208
kinetics (1186) 1186
prognosis (1171) 1171
toxicity (1152) 1152
adolescent (1050) 1050
creatine kinase - blood (1043) 1043
liver - enzymology (1033) 1033
apoptosis - drug effects (1019) 1019
cell line (1012) 1012
research (1011) 1011
in vitro techniques (1010) 1010
cancer (1009) 1009
l-lactate dehydrogenase - genetics (1007) 1007
alanine transaminase - blood (983) 983
cells (967) 967
cytotoxicity (963) 963
physiological aspects (962) 962
liver (937) 937
liver - drug effects (926) 926
rodents (906) 906
dehydrogenases (883) 883
in-vitro (882) 882
rabbits (860) 860
inflammation (838) 838
ischemia (838) 838
antioxidants (816) 816
research article (814) 814
histocytochemistry (803) 803
activation (792) 792
physiology (791) 791
myocardium - enzymology (782) 782
gene expression (781) 781
glucose (759) 759
liver - metabolism (758) 758
glutathione (755) 755
oxidative stress - drug effects (754) 754
muscles - enzymology (748) 748
medicine, research & experimental (732) 732
surgery (724) 724
cell line, tumor (722) 722
reactive oxygen species - metabolism (722) 722
inhibition (717) 717
dehydrogenase (712) 712
alkaline phosphatase - blood (708) 708
child (700) 700
aged, 80 and over (696) 696
medicine (689) 689
hydrogen-ion concentration (684) 684
immunology (681) 681
hematology (667) 667
cattle (662) 662
health aspects (662) 662
electrophoresis (657) 657
glutathione - metabolism (654) 654
analysis of variance (647) 647
mitochondria (646) 646
glycolysis (638) 638
methods (630) 630
retrospective studies (628) 628
hypoxia (621) 621
multidisciplinary sciences (618) 618
survival (617) 617
disease models, animal (614) 614
swine (590) 590
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21194) 21194
German (627) 627
Russian (386) 386
Japanese (253) 253
French (234) 234
Chinese (144) 144
Italian (142) 142
Spanish (106) 106
Polish (61) 61
Czech (32) 32
Bulgarian (24) 24
Portuguese (13) 13
Dutch (11) 11
Slovak (10) 10
Hungarian (8) 8
Romanian (8) 8
Serbian (7) 7
Ukrainian (7) 7
Turkish (6) 6
Croatian (5) 5
Norwegian (3) 3
Swedish (3) 3
Danish (2) 2
Hebrew (2) 2
Korean (2) 2
Afrikaans (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Prostate, ISSN 0270-4137, 07/2017, Volume 77, Issue 10, pp. 1144 - 1150
Background An array of clinical issues remains to be resolved for castration‐resistant prostate cancer (CRPC), including the sequence of drug use and drug... 
sequential therapy | androgen‐receptor axis‐targeted (ARAT) agents | lactate dehydrogenase (LDH) | combined progression‐free survival (PFS) | predictor of combined PFS | combined progression-free survival (PFS) | androgen-receptor axis-targeted (ARAT) agents | TRIAL | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | BONE | ACETATE | DOCETAXEL | CHEMOTHERAPY | Phenylthiohydantoin - adverse effects | Predictive Value of Tests | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - administration & dosage | Prostate-Specific Antigen - analysis | Prostatic Neoplasms, Castration-Resistant - pathology | Prostate - pathology | Antineoplastic Agents - adverse effects | L-Lactate Dehydrogenase - analysis | Prostate - drug effects | Retrospective Studies | Androstenes - adverse effects | Japan | Prostatic Neoplasms, Castration-Resistant - drug therapy | Androstenes - administration & dosage | Disease Progression | Phenylthiohydantoin - analogs & derivatives | Disease-Free Survival | Phenylthiohydantoin - administration & dosage | Aged | Drug Monitoring | Prostatic Neoplasms, Castration-Resistant - diagnosis | Hemoglobin | Development and progression | Prognosis | Prostate cancer | Analysis | Patient outcomes | Dehydrogenases | Castration | Prostate-specific antigen | Androgen receptors | Cross-resistance | Lactic acid | Multivariate analysis | Survival | Prostate | L-Lactate dehydrogenase
Journal Article